Published: 10 August 2024
Author(s): Giuseppina Tiziana Russo, Annalisa Giandalia, Giuseppe Lucisano, Maria Chiara Rossi, Pamela Piscitelli, Roberto Pontremoli, Francesca Viazzi, Alberto Rocca, Valeria Manicardi, Graziano Di Cianni, Riccardo Candido, Antonio Nicolucci, Salvatore De Cosmo, AMD Annals Study Group
Section: Original Article
Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease (ESKD) in the western world, accounting for more than 40 % of patients that require kidney replacement therapy [1]. It is also associated with higher cardiovascular and all-cause mortality [2].
